Psychiatry and Neurology, Neurology · Guaynabo, PR
NPI
1225340847
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
59 Ave Esmeralda, Urb. Munoz Rivera
Guaynabo, PR, 00969
Phone (787) 720-3234
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,712
85 services
Medicare patients, 2024
13
Average age 69
Drug cost, 2024
$1.4M
4,157 prescriptions
Company payments, 2025
$30K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Franchesca Fiorito-Torres was code 99214 (office e&m - established), 32 times for 13 patients. In total Franchesca Fiorito-Torres billed 85 services in 10 codes, and Medicare paid $7,712.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 32 | 13 | $89.54 | $2,865 |
By year: 2022 $7,348 for 103 services; 2023 $6,649 for 87 services; 2024 $7,712 for 85 services.
Medicare prescription drug claims, 2024
In 2024, the drug Franchesca Fiorito-Torres prescribed most often to Medicare patients was Emgality Pen (Galcanezumab-Gnlm), with 384 prescriptions and refills. In total Franchesca Fiorito-Torres wrote 4,157 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Emgality Pen Galcanezumab-Gnlm | 384 | 384 | 45 | $279K |
| Gabapentin Generic | 270 | 286 | 40 | $3,341 |
| Topiramate Generic | 253 | 273 | 28 | $2,018 |
| Tizanidine Hcl Generic | 233 | 233 | 42 | $2,814 |
| Nurtec Odt Rimegepant Sulfate | 228 | 228 | 30 | $272K |
| Amitriptyline Hcl Generic | 220 | 239 | 34 | $2,285 |
| Ajovy Autoinjector Fremanezumab-Vfrm | 209 | 209 | 26 | $155K |
| Ubrelvy Ubrogepant | 197 | 197 | 28 | $242K |
| Rizatriptan Rizatriptan Benzoate | 160 | 160 | 28 | $4,578 |
| Aimovig Autoinjector Erenumab-Aooe | 144 | 144 | 18 | $109K |
| Qulipta Atogepant | 118 | 118 | 15 | $131K |
| Diclofenac Potassium Generic | 94 | 96 | 18 | $4,205 |
| Eletriptan Hbr Eletriptan Hydrobromide | 93 | 93 | 12 | $8,421 |
| Reyvow Lasmiditan Succinate | 71 | 71 | 11 | $62K |
| Sumatriptan Succinate Generic | 68 | 68 | 11 | $2,017 |
Brand drugs: - claims; generic drugs: 2,720 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Franchesca Fiorito-Torres $30K ($30K in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $30K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.